| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Cash flows from operating activities | ||||||
Net loss | ||||||
-18,320 | -12,740 | |||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation | ||||||
1,888 | 1,850 | |||||
Depreciation and amortization | ||||||
447 | 63 | |||||
Debt discount amortization | ||||||
16 | - | |||||
Change in fair value of warrant liability | ||||||
- | 2,583 | |||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
473 | - | |||||
Inventory | ||||||
380 | - | |||||
Prepaid expenses and other assets | ||||||
1,361 | 663 | |||||
Accounts payable | ||||||
-377 | 413 | |||||
Accrued liabilities | ||||||
534 | 349 | |||||
Net cash used in operating activities | ||||||
-18,026 | -8,145 | |||||
Cash used in investing activities | ||||||
Purchases of property and equipment | ||||||
1,096 | 236 | |||||
Purchase of product licensing rights | ||||||
750 | - | |||||
Net cash used in investing activities | ||||||
-1,846 | -236 | |||||
Cash flows from financing activities | ||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | ||||||
- | 22,803 | |||||
Payments of initial public offering costs | ||||||
- | 843 | |||||
Proceeds from issuance of long-term debt, net of issuance costs | ||||||
4,750 | - | |||||
Proceeds from employee stock purchase plan and stock option exercises | ||||||
453 | - | |||||
Net cash provided by financing activities | ||||||
5,203 | 21,960 | |||||
Change in cash and cash equivalents | ||||||
-14,669 | 13,579 | |||||
Supplemental disclosures of non-cash investing and financing activities: | ||||||
Accrued dividends on redeemable convertible preferred stock | ||||||
- | 1,048 | |||||
Deemed dividends for accretion of redeemable convertible preferred stock issuance costs | ||||||
- | 1,694 | |||||
Relative fair value of common stock warrants issued in connection with debt | ||||||
226 | - | |||||
Purchases of equipment included in accounts payable | ||||||
- | 469 | |||||
Beneficial conversion feature on redeemable convertible preferred stock | ||||||
- | 21,747 | |||||
Reclassification of common stock warrants from liability to additional paid-in-capital | ||||||
- | 3,103 | |||||